标题
Detection of minimal residual disease in pediatric acute lymphoblastic leukemia
作者
关键词
-
出版物
CYTOMETRY PART B-CLINICAL CYTOMETRY
Volume 84, Issue 6, Pages 359-369
出版商
Wiley
发表日期
2013-06-12
DOI
10.1002/cyto.b.21101
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Flow Cytometric Identification and Functional Characterization of Immature and Mature Circulating Endothelial Cells
- (2012) Julie A. Mund et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia
- (2012) M. Faham et al. BLOOD
- OMIP-010: A new 10-color monoclonal antibody panel for polychromatic immunophenotyping of small hematopoietic cell samples
- (2012) Frank W. M. B. Preijers et al. CYTOMETRY PART A
- Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia
- (2012) G. Gaipa et al. HAEMATOLOGICA
- EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
- (2012) J J M van Dongen et al. LEUKEMIA
- Quality assurance for polychromatic flow cytometry using a suite of calibration beads
- (2012) Stephen P Perfetto et al. Nature Protocols
- High-Throughput Sequencing Detects Minimal Residual Disease in Acute T Lymphoblastic Leukemia
- (2012) D. Wu et al. Science Translational Medicine
- A deep profiler's guide to cytometry
- (2012) Sean C. Bendall et al. TRENDS IN IMMUNOLOGY
- Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation
- (2011) Xiao-Su Zhao et al. ANNALS OF HEMATOLOGY
- High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia
- (2011) W. Leung et al. BLOOD
- Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study
- (2011) M. Schrappe et al. BLOOD
- New markers for minimal residual disease detection in acute lymphoblastic leukemia
- (2011) E. Coustan-Smith et al. BLOOD
- Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia
- (2011) Giovanni Cazzaniga et al. BRITISH JOURNAL OF HAEMATOLOGY
- Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry
- (2011) Ingrid Thörn et al. BRITISH JOURNAL OF HAEMATOLOGY
- CD304 is preferentially expressed on a subset of B-lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometry
- (2011) Françoise Solly et al. CYTOMETRY PART A
- Polychromatic flow cytometry identifies novel subsets of circulating cells with angiogenic potential in pediatric solid tumors
- (2011) Kamnesh R. Pradhan et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Improved compensation of the fluorochrome AmCyan using cellular controls
- (2011) Joseph A. DiGiuseppe et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Prognostic value of MRD-dynamics in childhood acute lymphoblastic leukemia treated according to the MB-2002/2008 protocols
- (2011) Alexander N. Meleshko et al. LEUKEMIA RESEARCH
- Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: Results of Children's Oncology Group trial P9906
- (2011) W. Paul Bowman et al. PEDIATRIC BLOOD & CANCER
- CD11b is a therapy resistance- and minimal residual disease-specific marker in precursor B-cell acute lymphoblastic leukemia
- (2010) P. Rhein et al. BLOOD
- Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study
- (2010) V. Conter et al. BLOOD
- Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia
- (2010) P. Stow et al. BLOOD
- Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial
- (2010) Catriona Parker et al. LANCET
- Sequential monitoring of minimal residual disease in acute lymphoblastic leukemia: 7-year experience in a pediatric hematology/oncology unit
- (2010) Katerina Katsibardi et al. LEUKEMIA & LYMPHOMA
- Cytogenetic analysis of pediatric anaplastic large cell lymphoma
- (2010) Lara Mussolin et al. PEDIATRIC BLOOD & CANCER
- Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: A report from the Japanese Childhood Cancer and Leukemia Study Group
- (2010) Kazutaka Yamaji et al. PEDIATRIC BLOOD & CANCER
- Aberrant Underexpression of CD81 in Precursor B-Cell Acute Lymphoblastic Leukemia
- (2009) Tariq Muzzafar et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia
- (2009) Rosemary Sutton et al. BRITISH JOURNAL OF HAEMATOLOGY
- Advances in complex multiparameter flow cytometry technology: Applications in stem cell research
- (2009) Frederic Preffer et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-center setting;
- (2009) J. Irving et al. HAEMATOLOGICA
- Overexpression of CD123 correlates with the hyperdiploid genotype in acute lymphoblastic leukemia
- (2009) M. Djokic et al. HAEMATOLOGICA
- CD34+ cell subpopulations detected by 8-color flow cytometry in bone marrow and in peripheral blood stem cell collections: application for MRD detection in leukemia patients
- (2009) Elisabet Björklund et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Risk of Relapse of Childhood Acute Lymphoblastic Leukemia Is Predicted By Flow Cytometric Measurement of Residual Disease on Day 15 Bone Marrow
- (2009) Giuseppe Basso et al. JOURNAL OF CLINICAL ONCOLOGY
- Quality Control of Flow Cytometry Data Analysis for Evaluation of Minimal Residual Disease in Bone Marrow From Acute Leukemia Patients During Treatment
- (2009) Elisabet Björklund et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol
- (2009) V H J Van der Velden et al. LEUKEMIA
- Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
- (2009) Ching-Hon Pui et al. NEW ENGLAND JOURNAL OF MEDICINE
- Detection of residual B precursor lymphoblastic leukemia by uniform gating flow cytometry
- (2009) Ester Mejstříková et al. PEDIATRIC BLOOD & CANCER
- Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
- (2008) M. J. Borowitz et al. BLOOD
- Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches
- (2008) Jacqueline Ryan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible
- (2008) Michael Norbert Dworzak et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: Potential usefulness in minimal residual disease detection
- (2008) Joseph A. DiGiuseppe et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Minimal Residual Disease Values Discriminate Between Low and High Relapse Risk in Children With B-Cell Precursor Acute Lymphoblastic Leukemia and an Intrachromosomal Amplification of Chromosome 21: The Austrian and German Acute Lymphoblastic Leukemia Berlin-Frankfurt-Münster (ALL-BFM) Trials
- (2008) Andishe Attarbaschi et al. JOURNAL OF CLINICAL ONCOLOGY
- Reinduction Platform for Children With First Marrow Relapse of Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
- (2008) Elizabeth A. Raetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group
- (2008) Peter Bader et al. JOURNAL OF CLINICAL ONCOLOGY
- Minimal residual disease is an important predictive factor of outcome in children with relapsed ‘high-risk’ acute lymphoblastic leukemia
- (2008) M Paganin et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started